Novo Biosciences, Inc. — Form D
Novo Biosciences, Inc. of Lamoine, ME, a company, filed a Form D exempt-offering notice with the SEC on 2015-07-16. The offering totals $1.0M, of which $75K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2015-07-16
- Form: D
- Accession: 0001648277-15-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $75K
- Remaining: $925K
- Minimum investment: $25K
- Investors: 2
- Date of first sale: 2015-07-03
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-243877
Issuer
- Name: Novo Biosciences, Inc.
- CIK: 0001648277
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 22 Partridge Cove Road, Lamoine, ME, 04605
- Phone: (202) 669 0208
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Denise Barbut | Director | Philadelphia, PA |
| Daniel Coit | Director | Bar Harbor, ME |
| Viravuth Yin | Director | Trenton, ME |
| Viravuth Yin | Executive Officer | Trenton, ME |
| Kevin Strange | Director | Lamoine, ME |
| Kevin Strange | Executive Officer | Lamoine, ME |
Other filings by this issuer (1)
More